Progress in neutron beam development at the HFR Petten (feasibility study for a BNCT facility)
Creators
- 1. JRC Petten (Netherlands)
- 2. AEA Technology, Harwell (United Kingdom)
- 3. Birmingham Univ. (UK)
- 4. Netherlands Energy Research Foundation, Petten (Netherlands)
Description
Boron Neutron Capture Therapy, using intermediate energy neutrons to achieve the deep penetration essential for treating brain tumours, can be implemented with a filtered reactor neutron beam. This is designed to minimize the mean energy of the neutrons to keep proton recoil damage to the scalp within normal tissue tolerance limits whilst delivering the required thermal neutron fluence to the tumour over a reasonably short period. This can only be realized in conjunction with a high power density reactor. At the Joint Research Centre Petten an optimized neutron filter is currently being built for installation into the HB11 beam tube of the High Flux Reactor HFR. Part of the development leading to this design has been an extensive study of broad spectrum, filtered beam performance on the HB7 beam tube facility. A wide range of calculations was performed using the Monte Carlo code, MCPN, supported by validation experiments in which several filter configuration incorporating aluminium, sulphur, liquid argon, titanium and cadmium were installed for low power measurements of the neutron fluence rate, neutron spectra and beam gamma-ray contamination. The measurements were carried out within a successful European collaboration. Evaluations were made of the reactor core edge and unfiltered beam spectra, for comparison with MCNP calculations. Multi-foil activation methods and also gamma dose determination in the filtered beam using thermo-luminescent detectors were performed by the ECN. The Harwell/ Birmingham University collaborators undertook the neutron spectrum measurements in the filtered beam. proton recoil spectrometry was used above 30 keV, combined with a multi-sphere and BF3 chamber response modification technique. Subsequent spectrum adjustment was carried out with the SENSAK code. The agreement between the calculated and measured spectra has given confidence in the reactor and filter modelling methods used to design the HB11 therapy facility. (author). 12 refs.; 6 figs.; 4 tabs
Availability note (English)
MF available from INIS under the Report Number.Files
22034367.pdf
Files
(518.1 kB)
| Name | Size | Download all |
|---|---|---|
|
md5:4fabf9d96177e2fb7215b63e380410e8
|
518.1 kB | Preview Download |
Additional details
Publishing Information
- Imprint Pagination
- 15 p.
- Report number
- ECN-RX--90-058
Conference
- Title
- 7. ASTM-Euratom symposium on reactor dosimetry.
- Dates
- 27-31 Aug 1990.
- Place
- Strasbourg (France).
INIS
- Country of Publication
- Netherlands
- Country of Input or Organization
- Netherlands
- INIS RN
- 22034367
- Subject category
- S62: RADIOLOGY AND NUCLEAR MEDICINE;
- Resource subtype / Literary indicator
- Conference
- Descriptors DEI
- BORON; BRAIN; FILTERS; HFR REACTOR; NEOPLASMS; NEUTRON BEAMS; NEUTRON CAPTURE THERAPY; NEUTRON FLUENCE
- Descriptors DEC
- BEAMS; BODY; CENTRAL NERVOUS SYSTEM; DISEASES; ELEMENTS; ENRICHED URANIUM REACTORS; IRRADIATION REACTORS; MATERIALS TESTING REACTORS; MEDICINE; NERVOUS SYSTEM; NEUTRON THERAPY; NUCLEON BEAMS; ORGANS; PARTICLE BEAMS; RADIOTHERAPY; REACTORS; RESEARCH AND TEST REACTORS; RESEARCH REACTORS; SEMIMETALS; TANK TYPE REACTORS; THERAPY; THERMAL REACTORS; WATER COOLED REACTORS; WATER MODERATED REACTORS
Optional Information
- Notes
- Submitted for publication.